Get up to 90% off - Urjas Oil X
Caberlact, a prescription drug, is manufactured in various forms such as Tablet. It is typically used for the treatment of Acromegaly, Prolactinoma.
The optimal dosage of Caberlact is largely dependent on the individual's body weight, medical history, gender and age. Individual symptoms and route of administration also determines the right dosage. Refer to the dosage section for a detailed discussion.
While these are the most often observed Caberlact side effects, there are can be others also. These have been listed below. Usually, these side effects of Caberlact go away soon, and do not persist beyond the duration of the treatment. However, if these continue for a longer time, consult your doctor right away.
Caberlact's effect during pregnancy is Mild and Severe while nursing. It is important to know if Caberlact has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Caberlact related warnings section.
Caberlact can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Caberlact in conditions like High Blood Pressure, Heart Disease, Depression. Other contraindications of Caberlact have been discussed in the sections ahead.
Drug interactions for Caberlact have been reported in the medical literature. See below for a complete list.
In addition to these precautions, you may also note that Caberlact is not safe while driving, and is is not addictive in nature.
Caberlact is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Based on research, the following side effects have been observed when Caberlact is used -
Severe
Moderate
Mild
Is the use of Caberlact safe for pregnant women?
Caberlact has mild to no side effects in pregnant women.
Is the use of Caberlact safe during breastfeeding?
Women who are breastfeeding, may experience serious side effects after taking Caberlact. So it is adviced to consult the doctor before using it.
What is the effect of Caberlact on the Kidneys?
Kidney can be affected by Caberlact. If you experience any unwanted effects of this drug, stop taking it. You should take it again only after medical advice.
What is the effect of Caberlact on the Liver?
The liver can be affected by Caberlact. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart Caberlact only after medical advice.
What is the effect of Caberlact on the Heart?
The heart can be affected by Caberlact. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart the medicine only after medical advice.
Caberlact should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Caberlact unless your doctor advises you to do so -
Is this Caberlact habit forming or addictive?
Caberlact does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Caberlact can make you feel drowsy.
Is it safe?
Caberlact is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
No, the use of Caberlact in mental disorders is not effective.
Interaction between Food and Caberlact
Due to the absence of research, it is difficult to say how Caberlact and food will interact.
Interaction between Alcohol and Caberlact
Taking [medicine] and alcohol at the same time may lead to mild side effects. Contact your doctor right away if you observe any side effects.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 174-176
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 239-240
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Dostinex® (cabergoline)